McKesson Corporation (MCK) continues to attract significant attention from the investor community. Sparking interest are multiple aspects including a consistent outperformance of the healthcare sector and the overall market. Furthermore,
MCK has demonstrated strong financials over the years. This is evidenced by a 366% growth to those who invested five years ago and an impressive current value of a $100 investment made 20 years ago. A few major moves have influenced this trend, including the completion of the acquisition of
Core Ventures, and the future spinoff of the Medical-Surgical Solutions business. An updated fiscal year 2026 financial outlook also suggests sustainability, as does Morgan Stanley's upward revision of
MCK's price target, and Wells Fargo maintaining an equal weight rating. PRISM Vision Holdings' acquisition is expected to drive future gains. However, some concerns like a sales miss in Q3 earnings and contraction of gross margin have also been noted. Additionally, the divestiture of Canada-Based Rexall and Well.ca businesses saw the stock decline, albeit the overall sentiment for the stock remains optimistic.
Mckesson Corporation MCK News Analytics from Thu, 05 Sep 2024 07:00:00 GMT to Thu, 12 Jun 2025 23:15:15 GMT -
Rating 7
- Innovation 5
- Information 8
- Rumor -3
